机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[2]William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.[3]Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[4]Clinical Science and Services, Royal Veterinary College, University of London, London, United Kingdom.
This paper was supported by the following grants: China
Scholarship Council 202006240301 to SL.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|3 区医学
小类|3 区肿瘤学
最新[2023]版:
大类|3 区医学
小类|3 区肿瘤学
第一作者:
第一作者机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.[2]William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Liu Shengzhuo,Liang Jiayu,Liu Zhihong,et al.The Role of CD276 in Cancers.[J].Frontiers in oncology.2021,11:654684.doi:10.3389/fonc.2021.654684.
APA:
Liu Shengzhuo,Liang Jiayu,Liu Zhihong,Zhang Chi,Wang Yang...&Wang Xianding.(2021).The Role of CD276 in Cancers..Frontiers in oncology,11,
MLA:
Liu Shengzhuo,et al."The Role of CD276 in Cancers.".Frontiers in oncology 11.(2021):654684